« Previous Next » American Journal of Obstetrics & Gynecology
Volume 201, Issue 1 , Pages 31.e1-31.e6 , July 2009

Rapid human immunodeficiency virus testing in obstetric outpatient settings: the MIRIAD study

Naomi K. Tepper, MD, MPH
- Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA
Sherry L. Farr, MSPH, PhD
- Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA
Susan P. Danner, BA
- Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA
Robert Maupin, MD
- Department of Obstetrics and Gynecology, Louisiana State University School of Medicine, New Orleans, LA
Steven R. Nesheim, MD
- Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA
Mardge H. Cohen, MD
- CORE Center, Stroger (formerly Cook County) Hospital, Chicago, IL
Yvette A. Rivero, BA
- Department of Obstetrics and Gynecology, University of Miami School of Medicine, Miami, FL
Mayris P. Webber, DrPH
- Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY
Marc Bulterys, MD, PhD
- CDC Global AIDS Program, Centers for Disease Control and Prevention, Beijing, China
Michael K. Lindsay, MD, MPH
- Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, GA
Denise J. Jamieson, MD, MPH
- Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA

Received 12 September 2008 ,Revised 1 December 2008 ,Accepted 26 February 2009.

Women who presented to prenatal care clinics in Atlanta, Baton Rouge, or New Orleans: MIRIAD Study, 2002-2005
^aEligibility criteria: gestational age ≥ 34 weeks, not in labor, and undocumented HIV statu

Women who presented to prenatal care clinics in Atlanta, Baton Rouge, or New Orleans: MIRIAD Study, 2002-2005
^aEligibility criteria: gestational age ≥ 34 weeks, not in labor, and undocumented HIV status during the current pregnancy.
HIV, human immunodeficiency virus; MIRIAD, Mother-Infant Rapid Intervention at Delivery.
Tepper. Rapid HIV testing in obstetric outpatient settings. Am J Obstet Gynecol 2009.
- Full-Size Image
- Download to PowerPoint

At the time of the study, Dr Nesheim was at the Department of Pediatrics, Emory University School of Medicine, Atlanta, GA.

This study was supported by the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention (CDC), under cooperative agreements U64/217724, 417719, 517715, 617734, and 479935.

Reprints not available from the authors.

The findings and conclusions in this article are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. Use of trade names is for identification purposes only and does not constitute endorsement by the Centers for Disease Control and Prevention or the Department of Health and Human Services.

Cite this article as: Tepper NK, Farr SL, Danner SP, et al. Rapid human immunodeficiency virus testing in obstetric outpatient settings: the MIRIAD study. Am J Obstet Gynecol 2009;201:31.e1-6.

PII: S0002-9378(09)00214-2

doi: 10.1016/j.ajog.2009.02.023

« Previous Next » American Journal of Obstetrics & Gynecology
Volume 201, Issue 1 , Pages 31.e1-31.e6 , July 2009